Adrenergic modulation of a spinal sympathetic reflex in the rat

Shaun Morrison, Y. Z. Ge

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Patients with spinal cord injury involving transection of the lower cervical or upper thoracic spinal cord can experience an autonomic hyperreflexia characterized by exaggerated blood pressure increases in response to visceral to somatic stimuli such as skin stimulation and urinary bladder or rectal distention. These cardiovascular responses are mediated by activation of spinal sympathetic reflex (SSR) circuits in the segments below the transection that are no longer controlled by their supraspinal inputs. We have examined the SSR in decerebrate, unanesthetized, paralyzed, artificially ventilated rats after acute spinal transection in the sixth cervical segment and have determined its sensitivity to i.v. administration of clonidine and other agents interacting with alpha-2 adrenergic receptors. The SSR amplitude, determined as the area of the averaged excitatory potential evoked on the splanchnic sympathetic nerve by single stimuli (300 μA) applied to the seventh thoracic dorsal root, was reduced to 14% ± 6% of control with a cumulative dose of clonidine of 27 μg/kg. This inhibition was completely reversed by rauwolscine, idazoxan and RX821002, but not by prazosin. Both guanabenz and UK-14304 also reduced the SSR amplitude (9% ± 3% of control at 0.4 mg/kg and 11% ± 6% of control at 0.08 mg/kg, respectively). These results indicate that activation of alpha-2 adrenergic receptors, within either the dorsal or intermediolateral horns of the spinal cord or within sympathetic ganglial can significantly reduce transmission of information through SSR circuits after spinal cord injury.

Original languageEnglish (US)
Pages (from-to)380-385
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume273
Issue number1
StatePublished - 1995
Externally publishedYes

Fingerprint

Adrenergic Agents
Reflex
Adrenergic alpha-2 Receptors
Clonidine
Spinal Cord Injuries
Spinal Cord
Thorax
Guanabenz
Autonomic Dysreflexia
Idazoxan
Splanchnic Nerves
Yohimbine
Spinal Nerve Roots
Prazosin
Horns
Evoked Potentials
Urinary Bladder
Blood Pressure
Skin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Adrenergic modulation of a spinal sympathetic reflex in the rat. / Morrison, Shaun; Ge, Y. Z.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 273, No. 1, 1995, p. 380-385.

Research output: Contribution to journalArticle

@article{c0e777e5eb794a1d98722706b256898d,
title = "Adrenergic modulation of a spinal sympathetic reflex in the rat",
abstract = "Patients with spinal cord injury involving transection of the lower cervical or upper thoracic spinal cord can experience an autonomic hyperreflexia characterized by exaggerated blood pressure increases in response to visceral to somatic stimuli such as skin stimulation and urinary bladder or rectal distention. These cardiovascular responses are mediated by activation of spinal sympathetic reflex (SSR) circuits in the segments below the transection that are no longer controlled by their supraspinal inputs. We have examined the SSR in decerebrate, unanesthetized, paralyzed, artificially ventilated rats after acute spinal transection in the sixth cervical segment and have determined its sensitivity to i.v. administration of clonidine and other agents interacting with alpha-2 adrenergic receptors. The SSR amplitude, determined as the area of the averaged excitatory potential evoked on the splanchnic sympathetic nerve by single stimuli (300 μA) applied to the seventh thoracic dorsal root, was reduced to 14{\%} ± 6{\%} of control with a cumulative dose of clonidine of 27 μg/kg. This inhibition was completely reversed by rauwolscine, idazoxan and RX821002, but not by prazosin. Both guanabenz and UK-14304 also reduced the SSR amplitude (9{\%} ± 3{\%} of control at 0.4 mg/kg and 11{\%} ± 6{\%} of control at 0.08 mg/kg, respectively). These results indicate that activation of alpha-2 adrenergic receptors, within either the dorsal or intermediolateral horns of the spinal cord or within sympathetic ganglial can significantly reduce transmission of information through SSR circuits after spinal cord injury.",
author = "Shaun Morrison and Ge, {Y. Z.}",
year = "1995",
language = "English (US)",
volume = "273",
pages = "380--385",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Adrenergic modulation of a spinal sympathetic reflex in the rat

AU - Morrison, Shaun

AU - Ge, Y. Z.

PY - 1995

Y1 - 1995

N2 - Patients with spinal cord injury involving transection of the lower cervical or upper thoracic spinal cord can experience an autonomic hyperreflexia characterized by exaggerated blood pressure increases in response to visceral to somatic stimuli such as skin stimulation and urinary bladder or rectal distention. These cardiovascular responses are mediated by activation of spinal sympathetic reflex (SSR) circuits in the segments below the transection that are no longer controlled by their supraspinal inputs. We have examined the SSR in decerebrate, unanesthetized, paralyzed, artificially ventilated rats after acute spinal transection in the sixth cervical segment and have determined its sensitivity to i.v. administration of clonidine and other agents interacting with alpha-2 adrenergic receptors. The SSR amplitude, determined as the area of the averaged excitatory potential evoked on the splanchnic sympathetic nerve by single stimuli (300 μA) applied to the seventh thoracic dorsal root, was reduced to 14% ± 6% of control with a cumulative dose of clonidine of 27 μg/kg. This inhibition was completely reversed by rauwolscine, idazoxan and RX821002, but not by prazosin. Both guanabenz and UK-14304 also reduced the SSR amplitude (9% ± 3% of control at 0.4 mg/kg and 11% ± 6% of control at 0.08 mg/kg, respectively). These results indicate that activation of alpha-2 adrenergic receptors, within either the dorsal or intermediolateral horns of the spinal cord or within sympathetic ganglial can significantly reduce transmission of information through SSR circuits after spinal cord injury.

AB - Patients with spinal cord injury involving transection of the lower cervical or upper thoracic spinal cord can experience an autonomic hyperreflexia characterized by exaggerated blood pressure increases in response to visceral to somatic stimuli such as skin stimulation and urinary bladder or rectal distention. These cardiovascular responses are mediated by activation of spinal sympathetic reflex (SSR) circuits in the segments below the transection that are no longer controlled by their supraspinal inputs. We have examined the SSR in decerebrate, unanesthetized, paralyzed, artificially ventilated rats after acute spinal transection in the sixth cervical segment and have determined its sensitivity to i.v. administration of clonidine and other agents interacting with alpha-2 adrenergic receptors. The SSR amplitude, determined as the area of the averaged excitatory potential evoked on the splanchnic sympathetic nerve by single stimuli (300 μA) applied to the seventh thoracic dorsal root, was reduced to 14% ± 6% of control with a cumulative dose of clonidine of 27 μg/kg. This inhibition was completely reversed by rauwolscine, idazoxan and RX821002, but not by prazosin. Both guanabenz and UK-14304 also reduced the SSR amplitude (9% ± 3% of control at 0.4 mg/kg and 11% ± 6% of control at 0.08 mg/kg, respectively). These results indicate that activation of alpha-2 adrenergic receptors, within either the dorsal or intermediolateral horns of the spinal cord or within sympathetic ganglial can significantly reduce transmission of information through SSR circuits after spinal cord injury.

UR - http://www.scopus.com/inward/record.url?scp=0028969101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028969101&partnerID=8YFLogxK

M3 - Article

VL - 273

SP - 380

EP - 385

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -